Mechanisms of cancer-related fatigue
- PMID: 17573453
- DOI: 10.1634/theoncologist.12-S1-22
Mechanisms of cancer-related fatigue
Abstract
Cancer-related fatigue (CRF) is one of the most prevalent symptoms patients with cancer experience, both during and after treatment. CRF is pervasive and affects patients' quality of life considerably. It is important, therefore, to understand the underlying pathophysiology of CRF in order to develop useful strategies for prevention and treatment. At present, the etiology of CRF is poorly understood and the relative contributions of the neoplastic disease, various forms of cancer therapy, and comorbid conditions (e.g., anemia, cachexia, sleep disorders, depression) remain unclear. In any individual, the etiology of CRF probably involves the dysregulation of several physiological and biochemical systems. Mechanisms proposed as underlying CRF include 5-HT neurotransmitter dysregulation, vagal afferent activation, alterations in muscle and ATP metabolism, hypothalamic-pituitary-adrenal axis dysfunction, circadian rhythm disruption, and cytokine dysregulation. Currently, these hypotheses are largely based on evidence from other conditions in which fatigue is a characteristic, in particular chronic fatigue syndrome and exercise-induced fatigue. The mechanisms that lead to fatigue in these conditions provide a theoretical basis for future research into the complex etiology of this distressing and debilitating symptom. An understanding of relevant mechanisms may offer potential routes for its prevention and treatment in patients with cancer.Disclosure of potential conflicts of interest is found at the end of this article.
Similar articles
-
Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue.Oncologist. 2007;12 Suppl 1:52-67. doi: 10.1634/theoncologist.12-S1-52. Oncologist. 2007. PMID: 17573456 Review.
-
Cancer-related fatigue: the scale of the problem.Oncologist. 2007;12 Suppl 1:4-10. doi: 10.1634/theoncologist.12-S1-4. Oncologist. 2007. PMID: 17573451 Review.
-
Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment.Oncologist. 2007;12 Suppl 1:11-21. doi: 10.1634/theoncologist.12-S1-11. Oncologist. 2007. PMID: 17573452 Review.
-
The pathophysiology of cancer-related fatigue: current controversies.Support Care Cancer. 2018 Oct;26(10):3353-3364. doi: 10.1007/s00520-018-4318-7. Epub 2018 Jun 30. Support Care Cancer. 2018. PMID: 29961146 Review.
-
Fatigue in older cancer patients: etiology, assessment, and treatment.Semin Oncol. 2008 Dec;35(6):633-42. doi: 10.1053/j.seminoncol.2008.08.005. Semin Oncol. 2008. PMID: 19027467 Review.
Cited by
-
[Cancer-related fatigue. Psychosocial support].Urologe A. 2012 Mar;51(3):413-20; quiz 421. doi: 10.1007/s00120-012-2844-3. Urologe A. 2012. PMID: 22399113 Review. German.
-
Psoas Muscle Volume Is a Predictive Marker of Fatigue and Anorexia in Prostate Cancer Patients Treated with Enzalutamide.JMA J. 2022 Oct 17;5(4):491-497. doi: 10.31662/jmaj.2022-0096. Epub 2022 Sep 20. JMA J. 2022. PMID: 36407065 Free PMC article.
-
Mental quality of life is related to a cytokine genetic pathway.PLoS One. 2012;7(9):e45126. doi: 10.1371/journal.pone.0045126. Epub 2012 Sep 25. PLoS One. 2012. PMID: 23049769 Free PMC article.
-
Karnofsky Performance Status as A Predictive Factor for Cancer-Related Fatigue Treatment with Astragalus Polysaccharides (PG2) Injection-A Double Blind, Multi-Center, Randomized Phase IV Study.Cancers (Basel). 2019 Jan 22;11(2):128. doi: 10.3390/cancers11020128. Cancers (Basel). 2019. PMID: 30678249 Free PMC article.
-
Recommendations for high-priority research on cancer-related fatigue in children and adults.J Natl Cancer Inst. 2013 Oct 2;105(19):1432-40. doi: 10.1093/jnci/djt242. Epub 2013 Sep 18. J Natl Cancer Inst. 2013. PMID: 24047960 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical